39 related articles for article (PubMed ID: 16908420)
21. Hard gelatin and hypromellose (HPMC) capsules: estimation of rupture time by real-time dissolution spectroscopy.
El-Malah Y; Nazzal S; Bottom CB
Drug Dev Ind Pharm; 2007 Jan; 33(1):27-34. PubMed ID: 17192248
[TBL] [Abstract][Full Text] [Related]
22. Time domain 1H NMR as a new method to monitor softening of gelatin and HPMC capsule shells.
Kuentz M; Rothenhäusler B; Röthlisberger D
Drug Dev Ind Pharm; 2006; 32(10):1165-73. PubMed ID: 17090439
[TBL] [Abstract][Full Text] [Related]
23. Influence of capsule shell composition on the performance indicators of hypromellose capsule in comparison to hard gelatin capsules.
Al-Tabakha MM; Arida AI; Fahelelbom KM; Sadek B; Saeed DA; Abu Jarad RA; Jawadi J
Drug Dev Ind Pharm; 2015; 41(10):1726-37. PubMed ID: 25586554
[TBL] [Abstract][Full Text] [Related]
24. Effect of fill weight, capsule shell, and sinker design on the dissolution behavior of capsule formulations of a weak acid drug candidate BMS-309403.
Wu Y; Zhao F; Paborji M
Pharm Dev Technol; 2003; 8(4):379-83. PubMed ID: 14601962
[TBL] [Abstract][Full Text] [Related]
25. A comparison of the puncturing properties of gelatin and hypromellose capsules for use in dry powder inhalers.
Birchall JC; Jones BE; Morrissey A; Jones BE
Drug Dev Ind Pharm; 2008 Aug; 34(8):870-6. PubMed ID: 18686093
[TBL] [Abstract][Full Text] [Related]
26. Reviewing the use of ethylcellulose, methylcellulose and hypromellose in microencapsulation. Part 2: Techniques used to make microcapsules.
Rogers TL; Wallick D
Drug Dev Ind Pharm; 2011 Nov; 37(11):1259-71. PubMed ID: 21615294
[TBL] [Abstract][Full Text] [Related]
27. Challenges and opportunities in the encapsulation of liquid and semi-solid formulations into capsules for oral administration.
Cole ET; Cadé D; Benameur H
Adv Drug Deliv Rev; 2008 Mar; 60(6):747-56. PubMed ID: 18096270
[TBL] [Abstract][Full Text] [Related]
28. [A review on liquid-filled hard gelatin capsules].
Ma JH; Yang M; Zeng M; Chen XM; Lan J
Zhongguo Zhong Yao Za Zhi; 2008 Mar; 33(5):602-5. PubMed ID: 18536390
[TBL] [Abstract][Full Text] [Related]
29. Evaluation and comparison of physicomechanical characteristics of gelatin and hypromellose capsules.
Missaghi S; Fassihi R
Drug Dev Ind Pharm; 2006 Aug; 32(7):829-38. PubMed ID: 16908420
[TBL] [Abstract][Full Text] [Related]
30. HPMC capsules: current status and future prospects.
Al-Tabakha MM
J Pharm Pharm Sci; 2010; 13(3):428-42. PubMed ID: 21092714
[TBL] [Abstract][Full Text] [Related]
31. Gelatin and Non-Gelatin Capsule Dosage Forms.
Gullapalli RP; Mazzitelli CL
J Pharm Sci; 2017 Jun; 106(6):1453-1465. PubMed ID: 28209365
[TBL] [Abstract][Full Text] [Related]
32. The use of hypromellose in oral drug delivery.
Li CL; Martini LG; Ford JL; Roberts M
J Pharm Pharmacol; 2005 May; 57(5):533-46. PubMed ID: 15901342
[TBL] [Abstract][Full Text] [Related]
33. Reviewing the use of ethylcellulose, methylcellulose and hypromellose in microencapsulation. Part 3: Applications for microcapsules.
Rogers TL; Wallick D
Drug Dev Ind Pharm; 2012 May; 38(5):521-39. PubMed ID: 21962077
[TBL] [Abstract][Full Text] [Related]
34. Reviewing the use of ethylcellulose, methylcellulose and hypromellose in microencapsulation. Part 1: materials used to formulate microcapsules.
Rogers TL; Wallick D
Drug Dev Ind Pharm; 2012 Feb; 38(2):129-57. PubMed ID: 21913871
[TBL] [Abstract][Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
